Rest Ez Inc.
REST EZ Inc. is a U.S.-based dietary supplement company that markets a sleep-aid soft gel capsule under the Rest EZ Sleep Aid Supplement name. The company sells through wholesale distributors, retail channels, and its own website, with manufacturing and packaging outsourced to an unaffiliated third party.
Fiscal year 2026 · change from previous year
Development 2021–2026
Business
Share of revenueOral soft gel capsules marketed to adults seeking help with sleep.
Bulk sales of the supplement to wholesalers and distributors.
Sales through retail outlets and chain stores.
Direct online sales through the company website.
Customers
Rest EZ sells primarily to adults over 18 who are looking for a sleep-aid supplement, with purchases flowing through wholesalers, retailers, and the company website. The business also depends on trade customers such as wholesale distributors and retail stores that place orders and help broaden market reach. Its customer base is still developing, so repeat purchase behavior and channel adoption are important to the model.
Adults seeking an oral sleep-aid supplement for bedtime use.
Buy bulk product for redistribution into retail and other channels.
Stock the product for shelf sales to supplement shoppers.
Purchase through the company website for convenience and access.
Strategy
Rest EZ’s strategy is to build brand awareness for its sleep-aid capsule and expand distribution through wholesalers, retailers, and direct online sales. The company emphasizes word-of-mouth marketing, point-of-sale materials, and relationship-building with trade customers to widen its reach and support repeat purchases.
Broader channel access is central to scaling a single-product supplement business.
A new consumer supplement depends on recognition and customer loyalty to sustain demand.
E-commerce provides direct access to consumers and reduces dependence on intermediaries.
Geography
Rest EZ is incorporated in Wyoming and markets its product across the United States through wholesale, retail, and online channels. The reports describe nationwide distribution rather than a single regional concentration, so the business is exposed to U.S. consumer demand and domestic supplement retail channels. Manufacturing is outsourced to an unaffiliated provider, while sales and customer acquisition are managed from the company’s U.S. base.
Risks
Rest EZ faces the typical risks of a small consumer supplement company: limited brand awareness, intense competition, and dependence on a narrow product line. The business also relies heavily on a single executive and an outsourced manufacturer, which increases operational concentration and execution risk.
- Brand awareness may not develop sufficientlyImpact: HighLikelihood: Medium
A new supplement needs recognition and referral momentum to generate demand.
Exposure: Consumer acquisition and repeat sales
- Competition from established sleep-aid supplement brandsImpact: HighLikelihood: Medium
Larger competitors have greater marketing budgets, distribution, and name recognition.
Exposure - Key-person dependence on the sole officer and directorImpact: HighLikelihood: Medium
The company’s sales, relationships, and execution depend heavily on one individual.
Exposure: Management continuity
- Dependence on a single productImpact: High
Revenue is tied to one sleep-aid capsule, so demand weakness directly affects the business.
Exposure: Product concentration
- Supplier concentration and outsourced manufacturingImpact: Medium
Production is handled by an unaffiliated third party under a verbal arrangement.
Exposure: Supply continuity and product quality
Accounting
Judgemental itemsSales are made through wholesale, retail, and online channels, so timing of shipment and acceptance matters.
Impact: Affects reported revenue and quarter-to-quarter comparability
The company evaluates concentration of credit risk and collectability of receivables.
Impact: Can reduce reported assets and earnings if customers do not pay
Deferred tax assets depend on future taxable income that may not be realized.
Impact: Can materially affect tax expense and net assets
The company discloses limited capital resources and dependence on additional financing.
Impact: Affects financial statement presentation and investor interpretation
Similar listed companies
Publicly listed companies with a comparable business focus.
La-Z-Boy Incorporated
LZB · Household Furniture
LENZ Therapeutics, Inc.
LENZ · Biological Products, (No Diagnostic Substances)
LENZ Therapeutics is a U.S.-based pre-commercial biopharmaceutical company focused on developing and commercializing VIZZ, an aceclidine-based eye drop for presbyopia.
Rezolute, Inc.
RZLT · Pharmaceutical Preparations
Jazz Pharmaceuticals plc
JAZZ · Pharmaceutical Preparations
Jazz Pharmaceuticals plc is a biopharmaceutical company focused on medicines for serious diseases, with a portfolio centered on neuroscience and oncology.
Zynex Inc
ZYXIQ · Electromedical & Electrotherapeutic Apparatus
Clene Inc.
CLNN · Pharmaceutical Preparations
Last updated: 24/09/2026